Ontx Stock Forecast 5 Years
Based on 2 wall street analysts offering 12 month price targets for onconova therapeutics in the last 3 months. Earnings growth for 2020 is a modest +70%.
Monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis
Ontx stock forecast 5 years. 43.754 * about the onconova therapeutics, inc. Stock forecast as of 2021 december 04, saturday current price of ontx stock is 2.640$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). On average, they anticipate onconova therapeutics' share price to reach $11.50 in the next twelve months.
Amc price would move from $65.38 to $122.38, which is up 87%. Tonix pharmaceuticals holding stock forecast, tnxp stock price prediction. The average price target is $11.00 with a high forecast of $11.00 and a low forecast of $11.00.
That means +98% from today. This suggests a possible upside of 322.8% from the stock's current price. Ontx industry sector(s) s&p 500;
33.868 * about the nextech ar solutions corp stock forecast as of 2021 december 02, thursday current price of nexcf stock is 1.180$ and our data indicates that the asset price has been. (nasdaq:ontx)’s major holders onconova therapeutics, inc. Earnings growth (this year) +52.70%:
Earnings growth (last year) +90.33%: 5 year onconova therapeutics forecast: The average price target represents a 129.65% change from the last price of $4.79.
Its 4 year cash and equivalents growth rate is now at 83.81%. Insiders hold 0.56% of total outstanding shares, with institutional holders owning 11.21% of the shares at 11.28% float percentage. With 12 weeks representing a meaningful part of a year, this time period will show whether a stock has been enjoying strong investor demand, or if it's in consolidation, or distress.
Analyst price target on ontx. Volume has increased on the last day by. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
5 year nextech ar solutions forecast: While 2021 is set for a 70% return in earnings, projections for the next 5 years are at 0% annually. Ontx is unprofitable, and losses have increased over the past 5 years at a rate of 4.1% per year.
Ontx) has priced an underwritten public offering of 5 million shares at.20 for gross proceeds of million. Over the past 33 months, ontx's revenue has gone down $1,001,000. Their forecasts range from $11.00 to $12.00.
Amc will start 2023 at $65.38, then soar to $69.03 within the first six months of the year and finish 2023 at $70.06. The year over year cash and equivalents growth rate now stands at 54.68%. According to the issued ratings of 2 analysts in the last year, the consensus rating for onconova therapeutics stock is buy based on the current 2 buy ratings for ontx.
Stock advisor launched in february of 2002. These five years would bring an increase:
Post a Comment for "Ontx Stock Forecast 5 Years"